Literature DB >> 12169268

Temperature-dependent localization of TLS-CHOP to splicing factor compartments.

Melker Göransson1, Marianne Wedin, Pierre Aman.   

Abstract

The myxoid/round cell liposarcoma oncogene TLS-CHOP belongs to a growing family of tumor type specific fusion genes generated by chromosome translocations. We have recently found that the TLS-CHOP fusion protein is localized to well-defined nuclear structures, a pattern distinct from normal TLS or CHOP cellular distribution. Since location and function are intimately coupled in the organized nucleus, the aberrant localization of the fusion protein most certainly reflects the oncogenic activities of TLS-CHOP. We have investigated the role of the functionally unknown, SYGQ-rich, TLS N-terminal in the localization of TLS-CHOP to nuclear structures. Here, we report the temperature-dependent localization of TLS-CHOP to splicing factor compartments and association with Cajal bodies. Further, mutational analysis of the N-terminal part of green fluorescent protein-tagged TLS-CHOP identifies a region within the N-terminal required for colocalization with the splicing factor SC-35.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12169268     DOI: 10.1006/excr.2002.5566

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  9 in total

1.  Engineered protein disaggregases mitigate toxicity of aberrant prion-like fusion proteins underlying sarcoma.

Authors:  Jeremy J Ryan; Macy L Sprunger; Kayla Holthaus; James Shorter; Meredith E Jackrel
Journal:  J Biol Chem       Date:  2019-06-05       Impact factor: 5.157

Review 2.  TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration.

Authors:  Clotilde Lagier-Tourenne; Magdalini Polymenidou; Don W Cleveland
Journal:  Hum Mol Genet       Date:  2010-04-15       Impact factor: 6.150

Review 3.  Ectopic biomolecular phase transitions: fusion proteins in cancer pathologies.

Authors:  Richoo B Davis; Mahdi Muhammad Moosa; Priya R Banerjee
Journal:  Trends Cell Biol       Date:  2022-04-25       Impact factor: 21.167

4.  FET fusion oncoproteins interact with BRD4 and SWI/SNF chromatin remodelling complex subtypes in sarcoma.

Authors:  Malin Lindén; Christoffer Vannas; Tobias Österlund; Lisa Andersson; Ayman Osman; Mandy Escobar; Henrik Fagman; Anders Ståhlberg; Pierre Åman
Journal:  Mol Oncol       Date:  2022-03-19       Impact factor: 7.449

5.  FUS-DDIT3 prevents the development of adipocytic precursors in liposarcoma by repressing PPARgamma and C/EBPalpha and activating eIF4E.

Authors:  Pedro A Pérez-Mancera; Camino Bermejo-Rodríguez; Manuel Sánchez-Martín; Fernando Abollo-Jiménez; Belén Pintado; Isidro Sánchez-García
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

6.  NKAP is a novel RS-related protein that interacts with RNA and RNA binding proteins.

Authors:  Bhagyashri D Burgute; Vivek S Peche; Anna-Lena Steckelberg; Gernot Glöckner; Berthold Gaßen; Niels H Gehring; Angelika A Noegel
Journal:  Nucleic Acids Res       Date:  2013-12-17       Impact factor: 16.971

7.  The FUS-DDIT3 Interactome in Myxoid Liposarcoma.

Authors:  Jamie S E Yu; Shane Colborne; Christopher S Hughes; Gregg B Morin; Torsten O Nielsen
Journal:  Neoplasia       Date:  2019-06-17       Impact factor: 5.715

8.  DDIT3/CHOP and the sarcoma fusion oncoprotein FUS-DDIT3/TLS-CHOP bind cyclin-dependent kinase 2.

Authors:  Christoffer Bento; Mattias K Andersson; Pierre Aman
Journal:  BMC Cell Biol       Date:  2009-12-17       Impact factor: 4.241

9.  The oncogenic transcription factor FUS-CHOP can undergo nuclear liquid-liquid phase separation.

Authors:  Izzy Owen; Debra Yee; Hala Wyne; Theodora Myrto Perdikari; Victoria Johnson; Jeremy Smyth; Robert Kortum; Nicolas L Fawzi; Frank Shewmaker
Journal:  J Cell Sci       Date:  2021-09-03       Impact factor: 5.235

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.